LNZAWHIGH SIGNALFINANCIAL10-K

LNZAW faces severe financial distress with stockholders' equity turning negative, cash reserves depleted by 70%, and new risk disclosures about material internal control weaknesses and potential delisting concerns.

The company has moved into negative stockholders' equity territory (-$3.9M) while burning through most of its cash reserves, indicating potential liquidity constraints and heightened bankruptcy risk. The addition of material weakness disclosures and warnings about substantial shareholder dilution from warrant exercises suggests management is preparing investors for either distressed financing or potential restructuring scenarios.

Comparing 2026-03-31 vs 2025-04-15View on EDGAR →
FINANCIAL ANALYSIS

LNZAW's financial position has deteriorated dramatically, with stockholders' equity collapsing from $13.4M to negative $3.9M while cash reserves plummeted 70% to just $13.2M, indicating severe liquidity pressure. Despite reducing operating losses by 27% and cutting R&D expenses by 31%, the company appears to be in financial distress mode with assets declining 43% and inventory liquidated by 68%. The combination of negative equity, depleted cash, and reduced capital expenditures suggests the company is prioritizing survival over growth investments.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
-128.9%
$13.4M-$3.9M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Capital Expenditure
Cash Flow
-76.3%
$5.3M$1.3M

Capex reduced 76.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-69.7%
$43.5M$13.2M

Cash declined 69.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Inventory
Balance Sheet
-68.3%
$2.2M$684K

Inventory drawn down 68.3% — strong sell-through or deliberate destocking; watch for supply constraints.

Net Income
P&L
+64.5%
-$137.7M-$49.0M

Net income grew 64.5% — bottom-line growth signals improving overall business health.

Current Assets
Balance Sheet
-60%
$99.3M$39.7M

Current assets declined 60% — monitor working capital adequacy and short-term liquidity.

Total Liabilities
Balance Sheet
-43.6%
$161.2M$90.9M

Liabilities reduced 43.6% — deleveraging improves balance sheet strength and financial flexibility.

Total Assets
Balance Sheet
-42.6%
$174.7M$100.2M

Total assets contracted 42.6% — asset sales, write-downs, or balance sheet optimization underway.

R&D Expense
P&L
-30.9%
$77.0M$53.2M

R&D spending cut 30.9% — could signal cost discipline or concerning reduction in innovation investment.

Operating Income
P&L
+27.3%
-$108.9M-$79.2M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-04-15
ADDED
We may not be successful in scaling our cohort-based commercialization model, which remains central to our long-term strategy.
Failure of LanzaJet to successfully complete, commission, scale and operate its initial facility or failure of third parties to adopt the LanzaJet process in their commercial facilities for the production of SAF may severely impact our business, financial condition, results of operations and prospects.
4 Our stockholders will experience substantial dilution as a result of the exercise of the PIPE Warrant (as defined below) and the consummation of any additional equity financing, and Nasdaq has used its discretionary authority to delist securities in largely dilutive transactions.
There has not been an active market for trading in our common stock, and the Preferred Stock Conversion (as defined below) and the January 2026 Financing (as defined below) have concentrated, and the exercise of the PIPE Warrant and the consummation of any additional equity financing will concentrate, our share ownership and could further limit trading activity.
Khosla Ventures and its affiliates have significant influence over us, and their interests may conflict with those of our other stockholders in the future.
+7 more — sign up free →
REMOVED
lnza-20241231 FY 0001843724 false 2024 P3Y P3Y http://fasb.org/us-gaap/2024#AccountsAndOtherReceivablesNetCurrent http://fasb.org/us-gaap/2024#AccountsAndOtherReceivablesNetCurrent P2Y .6666 Insider Trading Policies We have adopted insider trading policies and procedures governing the purchase, sale, and/or other disposition our securities by directors, officers and employees, or by LanzaTech itself, designed to promote compliance with insider trading laws, rules and regulations and with the listing standards of the Nasdaq Stock Market ( Nasdaq ) applicable to LanzaTech.
Business Overview Founded in 2005 in New Zealand and now headquartered in Skokie, Illinois, we are a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition.
Our goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience.
Gas fermentation, a core part of our offering, enhances waste carbon value while minimizing environmental impact by using existing industrial land and recycled water.
Our biological process, akin to brewing, uses microbes to convert waste carbon into ethanol and derivatives.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →